Boston Scientific Taxus
This article was originally published in The Gray Sheet
Executive Summary
First PMA module for paclitaxel-eluting coronary stent is submitted to FDA. The fifth and final module will be submitted in June and include TAXUS IV clinical trial data. The results will be presented at the Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C. in September (1"The Gray Sheet" Feb. 3, 2003, p. 4)...